Login
Toggle navigation
Videos
Categories
Trending
The pandemic accelerated our focus on operational resilience and digital transformation.
00:10:00
Watch Full Video
×
Please Login to watch Full video
Login
+ ADD TO Wishlist
×
Please login
Login
Share On Facebook
Share On Twitter
Doron Blachar is Chief Executive Officer, Ormat Technologies Inc.
Recent Videos
00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
Suggestions
00:10:00
Canaan is a long-time early stage investor|Brent Ahrens,General Partner,Canaan Partners
00:10:00
Investing in India's Growth Story: Insights from Amar Kalkundrikar of Nippon India Mutual Fund | Amar Kalkundrikar - Fund Manager, Nippon India Mutual Fund
00:10:00
Shahar Bar, SVP of Video Products & Corporate Development at Harmonic Inc., discusses competition in the media industry.
00:10:00
Advancing Exploration and Development: Hay Street Project in Australia's Northern Territory
00:10:00
Aboitiz Group President and CEO Erramon Aboitiz delivers the 2017 New Year message, highlighting achievements and goals for Aboitiz Equity Ventures Inc.
00:10:00
Transforming Loan Markets: Arnaud Teissier on iLex's Innovation in Maritime Finance | Arnaud Teissier - Co-founder & Head of Sales, iLex
00:10:00
CompoSecure CEO Jon Wilk Talks SPAC Debut, Metal Credit Cards, and Arculus | Jon Wilk - CEO of CompoSecure
00:10:00
Palomino Minerals Explores High-Potential Gold Projects in Peru's Puno Orogenic Gold Belt
00:10:00
Navigating Rising Risks: David Kudla's Investment Strategy and Opportunities | David Kudla, CEO, Mainstay Capital Management.
00:10:00
Navigating Market Turbulence: Portfolio Strategies for Volatile Times | Insights from Yahoo Finance Experts
00:10:00
Starbucks CEO Howard Schultz Reaffirms Commitment to Company's Core Values and Mission, Declares Optimism for Future Success|Howard Schultz|CEO,Starbucks
00:10:00
Pelion Venture Partners helps entrepreneurs and invests in early-stage B2B|Jeff Kearl,Partner,Pelion Venture Partners